Workingtogetherto improve thehealthand well being of people with Multiple Sclerosis and other chronic neurologicalconditions. Our Centre started out over 25 years ago as people in Sussex with MS decided to get together and fundraise for treatment equipment, now were also helping people with other long-term health conditions such as Stroke, ME, and children with Cerebral Palsy and Autism to name but a few. We support each other in keeping control of our lives, countering isolation, and managing symptoms. You can come to the Centre and access a wide variety of drug free treatments, exercise classes and social opportunities to cater for differing needs. Our aims are to maintain flexibility and mobility, provide pain relief, and promote well-being and a positive attitude. We strive to keep our services affordable and we will never refuse you a treatment for financial reasons. We offer a variety of individual treatments, such as Hyperbaric Oxygen Therapy, Shiatsu, Massage, Acupuncture, Chiropody and Osteotherapy. We also have group activities such as Seated Exercise, Yoga, Pilates, Physio Gym, Tai Chi, Voice Work, Meditation and Fitness classes. There is a very popular weekly coffee morning, and we hold regular social events with live music or other entertainment. You can … Continue reading →

BBC News Risky treatment can stop multiple sclerosis for years BBC News A multiple sclerosis treatment being tested in patients can stop the disease for at least five years, say doctors. The risky therapy involves wiping out the person's immune system with strong cancer drugs and then rebooting it with a stem cell ... MS treatment that 'resets' immune system may halt disease progression for at least 5 yearsScienceBlog.com (blog) Multiple sclerosis: Stem cell transplantation may halt disease progressionMedical News Today Stem Cell Transplants May Help Some With MSWebMD Telegraph.co.uk -Mirror.co.uk -Daily Mail -The JAMA Network all 29 news articles » The rest is here: Risky treatment can stop multiple sclerosis for years - BBC News … Continue reading →

Apitope is developing therapeutic peptides to induce suppression of autoimmune responses towards self-antigens. Their recent phase IIa trial has revealed promising results for the treatment of multiple sclerosis. Multiple sclerosis (MS) is a hot topic these days.While arecentlong-term study revealedthe potential of hematopoietic stem cell transplantation for the treatment of MS, this treatment strategy is associated withlife-threatening complications mainly due toimmune deficiency. A very different approachis based on reinstating immune balance without causing global immune suppression. Apitopes technologyuses specific peptides, which induce an antigen-specific expansion of regulatory T cells the key mediatorsof immune tolerance. These cells are able to suppress autoantigen-specific helper T cells, which produce proinflammatory cytokines and are responsible for immune pathology in diseases such as MS. With itstechnology Apitope is trying to tackle four major disease areas includingMS, Graves Disease, Hemophilia type A and Uveitis. In 2009, Apitope licensed its MS lead ATX-MS-1467 to Merck KGaAin orderto develop and commercialize the treatment. However, Apitope announced that it regained full rights of their product in October 2016. Damage of the myelin sheath by the immune system in patients with multiple sclerosis. It seems like this was not a bad deal for Apitope as the company has now announced … Continue reading →

By Trevis Gleason Since the mid-1990s, the diagnosing process for most people suspected of having multiple sclerosis (MS) has included a lumbar puncture (also called a spinal tap) to look for certain antibodies and proteins, and an MRI scan to look for lesions in the brain. Previous to that, immersion into a hot tub (to see if symptoms worsened with heat) and evoked response tests may have been used. In the future, its possible that a test for blood biomarkers could become a standard part of the diagnostic process for MS and it could also help to determine the best form of treatment for those diagnosed. Earlier this month, Australian researchers announcedthey had discovered blood biomarkers of multiple sclerosis after 12 years of research. The biomarkers not only identify the presence of MS but also help to determine a persons stage of MS progression. While a commercial blood test using this research is not yet available, one is currently being developed. AnAustralian radio broadcaston the biomarker discovery gave a good sense of how the researchers see such a blood test for MS panning out. The researchers hope this type of blood testing might also prove helpful for people withmotor neuron … Continue reading →